EUVIMEDPoznaj EUVIMED
CrossrefKarta informacyjna

Unraveling the spatial landscape of dystrophinopathies: a transcriptomic approach to Becker and Duchenne muscular dystrophies

Laura GM Heezen, Qirong Mao, Stefan Nicolau, Claudio Novella Rausell, Julia van der Weerd, Jan Kueckelhaus, Rasya Gokul Nath, Jordi Diaz‐Manera, Hermien E Kan, Erik H Niks, Maaike van Putten, Annemieke Aartsma‐Rus, Kevin M Flanigan, Ahmed Mahfouz, Pietro Spitali

The Journal of Pathology · 2026-07 · 269 (3) · 363-380

DOI: 10.1002/path.70067 ↗
AbstraktDane bibliograficzne

Abstrakt

Abstract Dystrophinopathies are caused by pathogenic variants in the DMD gene, resulting in partial (Becker) or complete loss (Duchenne) of dystrophin. Becker (BMD) and Duchenne muscular dystrophy (DMD) are characterized by progressive muscle wasting, fatty replacement, fibrosis, and loss of function. To study histopathological changes, we used Visium spatial transcriptomics to profile skeletal muscle biopsies of patients affected by dystrophinopathy ( n = 8) and healthy controls ( n = 4). We estimated the proportion of cell types and their spatial localization across samples applying a deconvolution strategy using previously published single‐nucleus RNA‐sequencing data. We identified genes enriched in fat patches and cell types such as fibroadipogenic progenitors (FAPs) in areas of active pathology. Using expression data of ligand–receptor pairs, we highlight cell–cell communications leading to fibrotic and adipogenic lesions. Finally, analysis of gene expression gradients in areas of adjacent muscle and fat, allowed the identification of genes associated with muscle areas committed to becoming fat. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Wiedza dopasowana do Twojej pracy.

Od bezpłatnego startu przez osobiste wyszukiwanie literatury aż po pełny Research Suite.

Zobacz taryfy →

Czy wszystkie pełne teksty wydawców są dostępne?

Nie. Rekordy bibliograficzne, abstrakty i pełne teksty to różne treści. Dostępność zależy od źródła, otwartego dostępu i posiadanych licencji. Plan EUVIMED nie zastępuje dodatkowych praw wydawców.

Zobacz taryfy →